Ignite Creation Date:
2024-05-06 @ 6:25 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05657873
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2022-12-12
Brief Title:
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer NSCLC
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Study Overview
Official Title:
A Phase II Trial of Hepatic Ablation of Metastases to Modulate and Enhance Immunotherapy Response HAMMER in NSCLC
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to see whether adding liver stereotactic ablative radiotherapyL-SABR to standard drug therapy is better than standard drug therapy alone for people with metastatic non-small cell lung cancerNSCLC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None